Acute Graft Versus Host Disease - 162 Studies Found

Completed : Mesenchymal Stem Cells for Treatment of Refractory Acute Graft-versus-host Disease
: Acute Graft-versus-host Disease
: 2013-01-05
:
  • Biological: Mesenchymal stem cells

Active, not recruiting : Study of INCB039110 in Combination With Corticosteroids for the Treatment of Acute GVHD
: Acute Graft Versus Host Disease
: 2015-11-20
:
  • Drug: INCB039110 (200 mg)
  • Drug: INCB039110
Terminated : Tocilizumab for Treatment of Steroid Refractory Acute Graft-versus-Host Disease
: Acute Graft Versus Host Disease
: 2011-11-16
: Drug: Tocilizumab Tocilizumab will be administered intravenously at a dose of 8 mg/kg once every three w
Terminated : Phase I/II Trial rHuKFG for the Treatment of Steroid Refractory Gastrointestinal Acute GVHD
: Acute Graft Versus Host Disease
: 2002-06-05
: Drug: Recombinant Human Keratinocyte Growth Factor
Withdrawn : Anti-CD3 & Anti-CD7 Ricin A Immunotoxin-Combination for Acute Graft Versus Host Disease
: Acute Graft Versus Host Disease
: 2008-03-04
: Biological: IT-Combination The treatment consists of a standard dose of 4 infusions of IT-combination (4
Not yet recruiting : Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
: Acute-graft-versus-host Disease
: 2015-03-09
:
  • Drug: Cannabidiol Oral cannabi
Completed : The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease
: Acute Graft Versus Host Disease
: 2008-07-28
: Drug: Etanercept (Enbrel) Etanercept will begin within 72 hours of the diagnosis of Grade I acute GVHD a
Not yet recruiting : GRAVITAS-301: A Study of Itacitinib or Placebo in Combination With Corticosteroids for Treatment of Acute Graft-Versus-Host Disease
: Acute Graft-versus-host Disease
: 2017-05-02
:
  • Drug: Itacitinib Itacitinib at
Completed : Multicenter Study Of Natalizumab Plus Standard Steroid Treatment For High Risk Acute Graft-Versus-Host Disease
: Acute Graft Versus Host Disease
: 2014-05-06
:
  • Drug: natalizumab Natalizumab

Terminated : Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease
: Acute Graft-versus-Host Disease
: 2006-01-24
:
  • Drug: Methoxsalen+ECP, Methylprednisolone

Next >>>